The Role of Anthocyanins in Drug Discovery: Recent Developments

Curr Drug Discov Technol. 2020;17(3):286-298. doi: 10.2174/1570163816666190125152931.

Abstract

Natural compounds have always played a key role in drug discovery. Anthocyanins are secondary metabolites belonging to the flavonoids family responsible for the purple, blue, and red colour of many vegetables and fruits. These phytochemicals have attracted the interest of researchers for their important implications in human health and for their use as natural colorants. Many in vitro and in vivo studies demonstrated the potential effects of anthocyanins and anthocyanins-rich foods in the prevention and/or treatment of diabetes, cancer, and cardiovascular and neurodegenerative diseases. This review reports the recent literature data and focuses on the potential role of anthocyanins in drug discovery. Their biological activity, analysis of structure-activity relationships, bioavailability, metabolism, and future prospects of their uses are critically described.

Keywords: Anthocyanins; bioactivities; bioavailability; drug discovery; ferulic acid; future prospects.

Publication types

  • Review

MeSH terms

  • Anthocyanins / chemistry
  • Anthocyanins / pharmacology*
  • Anthocyanins / therapeutic use
  • Biological Availability
  • Cardiovascular Diseases / drug therapy
  • Diabetes Mellitus / drug therapy
  • Drug Discovery*
  • Fruit / chemistry
  • Humans
  • Neoplasms / drug therapy
  • Neurodegenerative Diseases / drug therapy
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Structure-Activity Relationship
  • Vegetables / chemistry

Substances

  • Anthocyanins
  • Plant Extracts